Skip to main content

When to Stop Aspirin Before CABG-Plus-Valve Surgery?

By Will Boggs MD
NEW YORK (Reuters Health) Jan 26 - The risk of bleeding after combined coronary artery bypass graft (CABG) and valve surgery is higher when chronic aspirin therapy is stopped within five days of the operation, compared to when it's stopped at least six days in advance.
The finding is from a review of such surgeries done at the Cleveland Clinic in Ohio, reported by Dr. Leslie Cho and colleagues.
Dr. Cho told Reuters Health by email that surgeons need to weigh the risk of bleeding vs. the benefit of aspirin before combined CABG/valve surgery.
"For example, if the patient has a drug-eluting stent and needs surgery, continuing aspirin makes sense,' Dr. Cho said. "However, if the patient is at high risk of bleeding" - because of anemia or older age, or because the surgery is a redo, for example - "then holding aspirin makes sense."
The data, from 1,963 patients on chronic aspirin therapy who underwent nonemergent CABG/valve surgery, were published online December 22 in the American Journal of Cardiology.
When patients were matched based on propensity scores, there was no difference between early and late aspirin discontinuation groups (i.e., within five days or at least six days pre-op) in the primary endpoint, a composite of in-hospital mortality, myocardial infarction, and stroke.
However, significantly more patients in the late-use group received postoperative transfusions (49% vs 42%, p=0.02), and there was a trend toward more reoperations for bleeding in the late-use group (6.1% vs 3.7%; p=0.08).
Guidelines from the Society of Thoracic Surgeons recommend that aspirin be stopped three to five days before elective CABG, whereas American College of Cardiology/American Heart Association guidelines suggest stopping 7 to 10 days in advance. Neither set of guidelines specifically addresses the issue of patients having combined CABG and valve surgery, the researchers note.
"For many years, surgeons and cardiologist had no real sense of when to stop aspirin," Dr. Cho said. "I hope with our study, they can make a logical decision about when to stop aspirin."
To better define patients' risk, Dr. Cho added, "We are currently planning to do a study looking at the level of aspirin function (arachidonic acid light transmittance aggregometry study) as relates to bleeding outcome."
Labels:

Comments

Post a Comment

Popular posts from this blog

Contact Precautions May Have Unintended Consequences

Contact precautions, including gloves, gowns, and isolated rooms, have helped stem the transmission of hospital pathogens but have also had some negative consequences, according to findings from a new study. Healthcare worker (HCWs) visited patients on contact precautions less frequently than other patients and spent less time with those patients when they did visit, report Daniel J. Morgan, MD, from the University of Maryland School of Medicine and the Veterans Affairs (VA) Maryland Health Care System, Baltimore, and colleagues. Moreover, patients on contact precautions also received fewer outside visitors. "Less contact with HCWs suggests that other unintended consequences of contact precautions still exist," Dr. Morgan and coauthors write. "The resulting decrease in HCW contact may lead to increased adverse events and a lower quality of patient care due to less consistent patient monitoring and poorer adherence to standard adverse event prevention methods (such...
Post a Comment
Read more

FDA Decision Delayed for Truvada in HIV PrEP

June 11, 2012 — The US Food and Drug Administration (FDA) has delayed its decision on allowing the use of tenofovir disoproxil fumarate/emtricitabine ( Truvada , Gilead) as preexposure prophylaxis (PrEP) so that the proposed risk evaluation and mitigation strategy (REMS) can be reviewed. In early May, the FDA's Antiviral Drugs Advisory Committee  strongly backed  approval of the first-ever drug for the prevention of sexually acquired HIV-1 infection. However, concerns by the panel at the time included that people may neglect condom use if they feel they are protected by PrEP. Panelists were also concerned that uninfected people taking PrEP who become infected with HIV may not switch to a 3-drug regimen as recommended. According to the company, the FDA has postponed the target date to September 14 so it can review Gilead's REMS plan to help ensure that patients will not misuse the drug. The committee's recommendation for supplemental approval of tenofovir/emtricit...
Post a Comment
Read more

Antidepressants Linked to Higher Diabetes Risk in Kids

Pediatric patients who use antidepressants may have an elevated risk for type 2 diabetes, the authors of a new study report. In a retrospective cohort study of more than 119,000 youths 5 to 20 years of age, the risk for incident type 2 diabetes was nearly twice as high among current users of certain types of antidepressants as among former users, Mehmet Burcu, PhD, and colleagues report in an article  published online October 16 in  JAMA Pediatrics . The risk intensified with increasing duration of use, greater cumulative doses, and higher daily doses of these antidepressants. The findings point to a growing need for closer monitoring of these products, including greater balancing of risks and benefits, in the pediatric population, the authors caution. They undertook the study because, despite growing evidence of an association between antidepressant use and an increased risk for type 2 diabetes in adults, similar research in pediatric patients was scarce. "To our know...
Post a Comment
Read more